Immune Pharmaceuticals Inc (fka IMNPQ)

[Letterpenny]

ESHA will not merge with Naya. It will only merge with Cytovia. There is good reason for that and that’s what will be happening in second half. I respect your thoughts Bruce even though you are completely wrong. Cytovia received backing already from same investors and they are just doubling down their investment to carry Cytovia into 2025. I’m sure there will be an update at the time of investment. But it will be minor and passive. Naya has no real value and will not receive the 116 million that ESHA is prepared to give in June. Be well. You also have a great holiday. Too bad you’re wrong here. It sucks being wrong. Eh. lol. Enjoy. Hula Hula Cuckoo Penny

[Letterpenny]

Hey folk, truth be known. Cytovia will not merge with anyone next year. That’s a F-ing pipe dream. They will remain private until all add-on mergers have been completed. Just my opinion., The mergers alone will take time and resources. I see Cytovia merging in 2025 after ESHA merger. So maybe in later part of 2024 but most likely in 2025. Cytovia doesn’t have to report any third year update to any shareholders. It’s Private people. Cytovia isn’t obligated to do jack shit despite what certain people want to think. So just enjoy Naya’s growth in 2024 and enjoy the ride. Happy Holidays Bruce and keep on wishful thinking. Keep believing, Sometimes wishes do come true. Hula Hula Cuckoo Penny

[Letterpenny]

RLK, I guess they could say something about Bertiliumumab since they acquired in bankruptcy. I’m thinking the acquisition of Immune Pharmaceuticals wouldn’t matter in this case. So yes it’s very possible that we could see something. I’m more interested in liquidity, not that I can do anything. Hands are tied until buy out is completed. We still have a long road ahead of us. It will be great to see the add-on mergers competed next year. Value will just compound throughout the year for Naya. Then maybe we could see Naya absorbed into Cytovia the following year. I’m still curious about Immune and its FINRA filing. It doesn’t need to make things public so we could be waking up one day to a surprise. Lots of fun. Hula Hula Cuckoo Penny

[Letterpenny]

Pretty sure RLK that Astra can’t and won’t announce anything in regards to a drug under a company that hasn’t been acquired yet. Hula hula cuckoo Penny

[trader59]

Immune Pharmaceuticals in New Jersey is the issuer of the revoked stock FKA IMNPQ, which is what you own and the subject of this board.

There is no Immune Pharmaceuticals owned by Astra Zeneca. You made that up. All part of the delusional state you're in.

[Letterpenny]

How are the casinos treating you? Keep living the life what dreams are made of. Hula Hula Cuckoo Penny

[Letterpenny]

I agree trader59 but I don’t know why you are referencing Immune Pharmaceuticals that went bankrupt in New Jersey. I’m referring to the other Immune Pharmaceuticals that’s alive and well and owned by Astra Zeneca. That’s the one that will eventually merge with Cytovia. Who knows trader, maybe they do a huge 360 turn and do something else to really mess with people. I look forward to all the add-on mergers coming next year with Naya. I can’t wait to see ESHA do its thing. I want to see if my suspicions are correct. I have placed huge bets on my keen intuition. Maybe I’m not just all crazy and a bag of hot air. 2025 will be great. Crossing my fingers. Hula Hula Cuckoo Penny

[trader59]

Nobody is merging with Immune, it is bankrupt, being liquidated and shut down. It would be stupid to merge with a dead company with no assets, no employees, no business operations, and revoked stock, even more stupid than investing in a company in bankruptcy (in this case, a total loss).

[Letterpenny]

So I guess Naya is the New Pharmaceutical Project that will be merged into after Immune and Cytovia merge. After all said and done the buy out will finalize soon after. This may be a good thing tax wise for me, especially if they can wrap up the sale so many months down the road but still make it timely enough that I can use sale price to recoup and pay off the substantial tax burden. Reverse merger puts us on Nasdaq so shares should become qualified again. I just hope they remain qualified.. any thoughts on the not qualifying again after reverse merger. If the goal is to complete merger and then move on with new project, I can only assume that they would remain listed on exchange. Hula Hula Cuckoo Penny

[Letterpenny]

Just curious Bruce, what Bank you using for financing? I find it amazing that you found an institution that will give you that financing. I might use them down the road if terms are tight. Never can be too short on banks. Thanks. Hula Hula Cuckoo Penny

[Letterpenny]

News out about INVO regaining compliance and Cytovia hogwash. https://finance.yahoo.com/news/invo-bioscience-regains-compliance-nasdaq-140000704.html

[Letterpenny]

Bruce, RLK. Can’t believe it. If I haven’t been humiliated enough already. This build and buy strategy is super smart and very humbling for my ego. I guess I now can say good bye to my grandiose street holding. lol. I’m now thinking that Eric and other like minded folk have continued getting in on the ground floor of all these add-on businesses. Well thought out guys. To be an insider is a great tool. I don’t like that side of the business. I’m not one to be an insider or on boards. Have never been one to socialize or network. I like marching to the beat of my own drum. That’s what introverted, delusional, egocentric, narcissists do, lol. Can’t believe it. The more I read here the more I'm humbled. Congrats to all you guys including Mike, Eric and Bloom, I’m not trading any of these add-ons but I can see where you can grow your positions substantially for super cheap. I guess I bought in on the platform level like you all but missed out on the Build A Bear project. Obviously Cellectis is going to play a role now that Astra is taking a major position there as well. That’s a no brainer. It’s wise for Cellectis to acquire the cutting and paste tool that Mike likes so much. It will take a while for all these companies to join in but eventually in time all will be absorbed by Astra. Teper is merely a worker Bee for Astra and is simply assembling all the pieces needed to complete the acquired Frankenstein. We now have Satellos, ESHA next on the chopping block and then possibly Celectis separately down the road. Great plan Astra!!!. I finally see the full picture. Education is key people. It’s laughable, I won't even have a percentage in this behemoth by the time this is all said and done. lol. I guess I’ll still have my shares, my crumbled ego and good physical health. If I ever do this again, I’m going to be more prepared for the end game when they start doing the Add-Ons. That’s where all the smart people like yourselves come in and get everything for dirt cheap. And here I thought I did well. What a joke. Obviously not. Lessoned learned. Humbled until the cows come home. Love it people. Love it. It’s been fun. Hula Hula Cuckoo Penny

[Letterpenny]

I guess I was on to something. lol

“A buy-and-build strategy allows a GP to justify the initial acquisition of a relatively expensive platform company by offering the opportunity to tuck in smaller add-ons that can be acquired for lower multiples later on. This multiple arbitrage brings down the firm’s average cost of acquisition, while putting capital to work and building additional asset value through scale and scope. At the same time, serial acquisitions allow GPs to build value through synergies that reduce costs or add to the top line. The objective is to assemble a powerful new business such that the whole is worth significantly more than the parts.”

[Letterpenny]

Bruce. I agree that this more a build to buy strategy. No real return or any real liquidity moment until Astra is prepared to finalize its acquisition. They only need the other 50 percent. lol. Wish we were Cellectis. Astra seems to be pouring cash into them without problem. Too bad we weren’t on the first in line list. So much to get done before any payout. Financing will be very tough to get on squemish Penny stock. I can’t finance on low grade equity. Glad to hear you know some banks that will give you penny financing. I don’t know anyone in Canada that can work that type of magic. Good for you. It’s pays to be in the know. Cheers. Hula Hula Cuckoo Penny

[Letterpenny]

More money for Cellectis. https://www.cellectis.com/en/press/cellectis-announces-the-execution-of-the-subsequent-investment-agreement-with-astrazeneca/

[Letterpenny]

Hey Bruce and RLK. I’m not very good at this stuff. Based off your present understanding, would you say a 5 dollar listing price is the best call for price after reverse merger? Hula Hula Cuckoo Penny

[Letterpenny]

Exactly Bruce. Financing is the way to go which I will embrace in the short term. Sadlly, I must pay tax the following year. So I can finance in the mean time but eventually I will have to pay the piper based off the firs day listing price. The day any stock becomes qualified and tradable, I then will need to pay tax on that stock the following year. The way of the world. Hula Hula Cuckoo Penny

[Letterpenny]

Bruce, I want a very low valuation. The lower the listing price the better it is for me. The heat will rise if they cut the rates in second half of year. Hula Hula Cuckoo Penny

[Letterpenny]

Bruce. Any shares in new Naya company are separate than Cytovia. Our ownership in Cytovia is completely separate. I can assume you know this little fact. I am quite aware that the 18 million shares aren’t the end of the road. I just feel I deserve more than a few shares in that dinky company. Just my opinion. They need Satellos as well. And you’re right, ESHA needs to be done as well. Naya may come out of this as a distinct pure play. Who knows right. Hula Hula Cuckoo Penny

[Letterpenny]

I agree Bruce. You would think that Cytovia shareholders would need to be informed about a few things before Naya completing anything. Eventually the company will need our support. Hula Hula Cuckoo Penny

[Letterpenny]

Great job Mike on getting in on the ground floor with ICO. Hula Hula Cuckoo Penny

[Letterpenny]

Noticed how Teper mentioned 100 million was possible with 2024 partnerships to fund the clinical studies of the two products that were sold to Naya from Cytovia. Slick. I don’t know how I missed that. Lol. Not too bright I guess. So I think Bruce you may be on the right track. It may well be that Cytovia doesn’t get the 100 mil. It may likely be Naya that’s the lucky one. The next step with them merging into Cytovia is anyone’s guess. That’s another possibility if they get some success with their products. Hula Hula Cuckoo Penny

[Letterpenny]

Still don’t like my holding in Naya. I have no clue what Mike is referring to when it comes to Cytovia shareholders winning here. I guess the one paying no tax are doing ok but I’m sure they hate there dividend value. Pathetic. Cytovia Tx is where the value is. Hula Hula Cuckoo Penny

[Letterpenny]

I guess in the end I will just have to suffer guys with equity position in Naya. Didn’t plan on these guys doing this but it is what it is. If they do decide to absorb Naya then that’s when things will change again. Don’t know if that will happen right away. I could see your approach happen Bruce. Tough call. I’m more interested in Cytovia than Naya. lol. Hula Hula Cuckoo Penny

[Letterpenny]

Wonder when Immune will file with FINRA? That process needs to take place and it will take time as well Bruce. They would need to file early in the quarter to get that completed within your schedule. Hula Hula Cuckoo Penny

[Letterpenny]

Armistice has a sweet deal with INVO. DEF 14A came out for INVO. I wish I was that smart. Geez. Hula Hula Cuckoo Penny

[Letterpenny]

Let me remind you that this dividend recapitalization strategy is rarely used and is more common in times when buyouts are prevalent. This obviously is the case here. Things are so cheap and look so good to me. Yet, this merger dividend is insignificant and really only benefits few shareholders. I’m sure a few creditors are also not too happy as well with this approach. I’m referring to ones that aren’t in bed with Teper. Maybe that is one or two at best. Still though. Any number is meaningful to me. Any ways. I look forward to hearing thoughts on this strategy. It’s definitely the path less taken if I am somehow spot on here with my thinking. I agree with you on a few things regarding Immune and Cytovia finding the means to an end here. I just find it odd that no one seems to be mentioning the distribution ratio. And how shitty that is for Naya shareholders. I will wait patiently for you or RLK to share your thoughts. I guess Mike has found new love for Teper. Good for you Mike for getting back on the horse. Be well. Hope you are lapping it up enjoying a wonderful Thanksgiving in some dirty casino in Reno. Hula Hula Cuckoo Penny.

[Letterpenny]

Hey Bruce. It’s funny how none of you are talking about the Naya deal and how shares holders of Naya get a total of 18 million shares. Let’s say you are correct and Naya remains separated, which I don’t believe, but let’s say it does for shits and giggle. Do you believe that the 7 shares per share is fare for legacy shareholders based on our ownership of Cytovia? Do you think it’s fare that the assets were basically given away for free? Yes I understand that many traders like yourself have gained from trading the shares but I’m not referring to that. I for one think all this is pretty shady shit and that everything isn’t adding up. Cause if this shit plays out the way you describe, then this ain’t the best deal for Cytovia private equity holders in any shape or form. So explain your thought process. Also, if there is any listing made, then I’m curious to see if this merger triggers certain transactions which will need to be finalized prior to merger being completed. This is in my mind a recapitalization play hence the money being funnelled into Cytovia and shares being rewarded to Naya shareholders. Not many mind you. Which is interesting and definitely feels like a squeeze from Teper. What’s also interesting is how this Bloom guy invested in this unproven Satellos company and has acquired 28 percent between himself and his company. That is fishy as hell. I sure wouldn’t squander money into a company that hasn’t proven Jack shit. And now Teper says that he’s investing in Ophthalmology company. Duh. No brainer what that is. The fact that his beneficial holding is in escrow for 36 months with all the others is also pretty telling. Any ways. I’m interested to hear what you and others think of the INVO 7 share deal. I see zero benefit unlike certain folk. Hula Hula Cuckoo Penny

[Letterpenny]

I wonder what Blooms percentage will be in the company. It will be interesting to see the final equity percentages. Hula Hula Cuckoo Penny

[Letterpenny]

I try to enjoy everyday that I breathe. Im not American RLK. You should know that. That’s ok I’m pretty forgettable. lol. Lucky me, I already ate my Canuck Thanksgiving turkey. It was amazing. Hey RLK, I will never forget where I come from thanks to me having to pay 70 percent tax on this investment. All thanks to my TFSA and the None qualifying shares that sit in that account. On top of that taxing, I also have to pay the Finance Minister each year a special tax just to have the shares. Only in Canada does a person have to endure this much pain. Yup. Lucky me. lol. What A Joke. Hula Hula Cuckoo Penny

[Letterpenny]

2024 will be a kick butt year watching Cytovia’s growth. Too bad us longs have to suffer through it for another year . LOL. So be it. It's all perfectly fine with me. I’m set to relax and enjoy the show.. Curious still about rates. I could see that relief given prior to mortgage renewals. Good times. What an amazing year we’ve had. Next year will be even better for dumb buyers like myself. I trust all of you are crushing it like me. Enjoy the turkey RLK. Hula Hula Cuckoo Penny

[Letterpenny]

At the same time guys getting regulated also could be a plus for Longs. It just means that the Feds are now accepting crypto as a viable market. It's that backend (blockchain) that holds the real value. I don’t follow this market so I can’t say to much more. I’m sure you pros know much more than me. I just watch and observe from a distance. Hula Hula Cuckoo Penny

[Letterpenny]

They could do a merger with an Immune if the rate cuts come sooner than later. That could be a great catalyst for them to play off of. I could see them do a couple cuts next year. I somehow feel they will be measured here and just wait and see. Staying private is not a bad plan. 2025 / 2026 will be great years to watch it build itself. S-3 filing is a beautiful thing. That’s the baby I like. Hula Hula Cuckoo Penny

[Letterpenny]

Looks like Crypto is about to get regulated. So glad I never got into that market. Lots more to come. Have a great day!!!!

[Letterpenny]

I still believe Cytovia will need more money. That should be done through the ESHA. 100 million will be sufficient to take them through to 2025. That merger is more reasonable than Naya merging with ESHA. Naya and Satellos recap is a great way to reorganize equity. He did mention two additional mergers coming so ESHA could play in that bit he released. 100 million would open that strategy up and money could be easily funnelled into Cytovia through a final merger between Naya and Cytovia. That’s also a good plan .They’ll want to delay the bankruptcy. That can easily be done. Disgorgment case. Who knows. I sure don’t. Hula Hula Cuckoo Penny

[Letterpenny]

Our holdings will be diluted huge through recap of companies. A nice squeeze. lol.. So we won’t be doing as well as expected but surviving is good. Cheers hula Hula cuckoo Penny

[Letterpenny]

Are you asking Bruce hence the emoji? My thought is that Cytovia will remain private and will not go public next year unless we see a cut in rates. I think Peter will carry on recapitalization strategy through Naya and other mergers like Satellos and possibly the SPAC ESHA which should happen in the second half. Remember, they need to feed the beast. I even thought Cytovia could do another recap with ESHA but that could be too repetitive. Nothing happening this year that’s for sure. Couple years to go. Hula Hula Cuckoo Penny

[Letterpenny]

Super quiet. I guess everyone has now parted now that Cytovia Tx has decided to remain private. Now it’s up to Naya to continue with doing nothing. Cytovia Tx basically gave the product to NAYA for nothing and INVO shareholders just joined a company with great product for cheap. What a deal for INVO shareholders. We should see something in couple years. Hula Hula Cuckoo Penny

[Letterpenny]

Bruce. Funnelling cash they go. Recapitalizing. Pooling investors through transient mergers. What a great plan. Good work Bloom. Gleeson. Same goes for all the INVO folk. Hilarious. Next year will definitely have a lot going on. Lots of gobbling. Hula Hula Cuckoo Penny

[Letterpenny]

Love this approach. “‘equality is equity’ as among ‘equally innocent victims,”’……What a great way of thinking. Sounds perfect to me. Pro rate is a great basis. Have a wonderful day. Hula Hula Cuckoo Penny

In upholding a plan of distribution that provided for pro rata distribution rather than a tracing approach, the Sixth Circuit held that “‘equality is equity’ as among ‘equally innocent victims,”’ further noting that “[t]he district court’s approach of pooling the receivership assets and distributing then on a pro rate basis is well supported….” Trade Partners, 572 F.3d at 298, 301 (citing Basic Energy, 273 F.3d 657, S.E.C. v. Credit Bancorp, Ltd., 290 F.3d 80, 88 (2d Cir. 2002), Forex, 242 F.3d 325, and Elliott, 953 F.2d 1560). In dicta, the Court indicated that even “ownership” of an asset would not necessarily defeat pooling rather than tracing, but would simply be one item for the district court to consider. Id., 300, n.1.

[Letterpenny]

Another one bites the dust. Stanley Frankel / Cytovia Tx case dismissed. And it was dismissed without prejudice. Hilarious. Of course it was. Crooks. Hula Hula Cuckoo Penny

THIS CAUSE came before the Court sua sponte. On August 17, 2023, the Court entered
an Order Administratively Closing Case [ECF No. 68] requiring the parties to file a stipulation of
dismissal within sixty (60) days of the Order. To date, no stipulation of dismissal has been filed,
nor have the parties requested additional time to comply. Accordingly, it is
ORDERED that the case is DISMISSED without prejudice.
DONE AND ORDERED in Miami, Florida, this 18th day of October, 2023.

[Letterpenny]

The plan Bruce is to delay for as long as possible while Naya a friends recapitalize merging with all these little scrumptious companies that are selling for cheap, I love that we’re now fertility lovers. I’m Pro life. Love life. Now we’re helping amazing ladies get the job done because society has crippled men into being weak minded pussies that couldn’t find their mojo. They simply don’t know how to chat with a beautiful lady of their choosing and try day and night to get the job done. It’s hilarious. They see boobies and they run. lol. Joking aside. This fertility process is great for people that need the extra help. These are great times we are living in. hula hula Cuckoo Penny

[Letterpenny]

No charm needed Bruce. The December 31st date was just for the first 600k owing which of course was only to be distributed if Israeli trustee had transferred the money. So Trustee just needs to say that cash wasn’t transferred and it out of his hands. Another 90 day extension will be given without any effort needed by Trustee, So look forward to absolutely nothingness coming other than theatre, nothing more nothing less. It’s the Holiday season, it’s cold outside, the cocoa is hot, war is ablaze.all around and It’s the most perfect time to sit back, relax and enjoy your 8 days of Christmas or your one day. Whatever you choose to believe. It’s a wonderful life. Hula Hula Cuckoo Penny

[Letterpenny]

You’re making me yawn Trader59. So repetitive. Hula Hula Cuckoo Penny

[trader59]

Nothing is happening, ever, to Immune Pharmaceuticals, the subject of this board. Immune Pharmaceuticals is in Chapter 7 bankruptcy, being liquidated and shut down. Your investment in it is a total loss. Here's the court docket if you ever get through rehab and want to know what really happened to your investment:

https://www.docketbird.com/court-cases/Immune-Pharmaceuticals-Inc/njb-2:2019-bk-13273

None of the other companies you babble about have anything to do with Immune Pharmaceuticals. You don't have equity in any of them.

[Letterpenny]

Lots of recapitalization coming our way. Which means lots more dilution to follow. Such is life. Hula Hula. 2027nshould be great liquidity year. Nothing planned for awhile as they explained in that last filing regarding the S-3 statement remain open for 36 months from time of filing. They will delay this forever. Lol. Patience is key. Hula Hula Cuckoo Penny

[Letterpenny]

This might help you Bruce. Astra Zeneca holds all rights now and I guess have given Immune permission to pursue another indication. Satellos just holds the one indication for Ophthalmology. All explained in this management discussion and analysis. I still believe in the Satellos merger. I would still want all if I were Astra. Astrahttps://satellos.com/wp-content/uploads/2022/05/Managements-Discussion-Analysis.pdf

Hula Hula Cuckoo Penny.

[Letterpenny]

Bruce. Satellos would have had to report the sale or assignment of any drug. Which they did not. I can only assume that they contracted out or outsourced which doesn’t need to be reported. I have zero clue how that was possible. The only rational in my head was what you reported is an old article. I went to the source and it doesn’t provide dates. Any ways. Good find Bruce. You must have been going down the rabbit hole on that one. Cheers. Hula Hula Cuckoo Penny

[Letterpenny]

Sometimes people have to drag their feet on purpose in order to delay the inevitable. The art of distraction. Frank is doing a great job of getting everyone focused on one product while the real truth is with another product. Good times. Hula Hula Cuckoo Penny

[Letterpenny]

I never said he wasn’t good swish. You seem to have the same hearing issue that many I know have. You people can’t seam t read between the lines. Frank Gleeson is a perfect CEO to get the job done with Teper next year. He has the right background to get the job done. Swish you need to work on your comprehension. Hula hula Cuckoo Penny